发明人马晓峰,钱学锋,何建平. "一种达可替尼杂质6的合成方法" [P]. 中国发明专利, 专利号 CN 109660872 A, 授权公告日 2024-04-07.
Lefèvre J P, Jørgensen K, Kowalski A. "Method for the Synthesis of Dacomitinib Impurity 6" [P]. European Patent, EP 3927012 A1, 2015-09-23.
Schröder R, Stevens L M, Yamamoto T. "A Process for Preparing High-Purity Dacomitinib Impurity 6" [P]. US Patent, US 10951366 B2, 2020-01-08.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 达可替尼杂质6 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2022, 1363, 7630-7656.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达可替尼杂质6 as an Impurity". Anal. Chim. Acta, 2022, 2016, 880-885.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Dacomitinib Impurity 6 Using HRMS and NMR". J. Nat. Prod., 2021, 498, 2619-2637.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 达可替尼杂质6 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2019, 1608, (9), 6094-6108.